April 8th, 2014
Study Suggests Link Between Viagra and Melanoma
Larry Husten, PHD
In recent years, researchers have uncovered a potentially important pathway whereby PDE5A inhibitors (which include sildenafil — Viagra — and other drugs used to treat erectile dysfunction and pulmonary hypertension) could potentially increase the risk for developing melanoma. Now a study provides early evidence showing an association between sildenafil and melanoma, though, like all observational […]
April 8th, 2014
Some Thoughts on E-Communication and the Future of Medicine
Ahmad M Slim, M.D.
Dr. Ahmad Slim discusses the rise of digital communication between physicians and patients.
April 8th, 2014
Assessing the MRI Safety of New Pacemakers and ICDs
Promporn Suksaranjit, M.D.
Promporn Suksaranjit provides an update on the safety of pacemakers and ICDs in an MRI environment.
April 7th, 2014
Selections from Richard Lehman’s Literature Review: April 7th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include SYMPLICITY HTN-3, CoreValve, MADIT-CRT, and more.
April 7th, 2014
Dabigatran Approved for Treatment of DVT and PE
Larry Husten, PHD
Boehringer Ingelheim announced on Monday that the FDA has approved dabigatran (Pradaxa) for the treatment of venous thromboembolism (VTE), which includes both deep venous thrombosis (DVT) and pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE in patients who have been previously treated. All three of the new oral anticoagulants — dabigatran, rivaroxaban […]
April 3rd, 2014
Cardiovascular Disease Declines in Rich Countries but Grows Elsewhere
Larry Husten, PHD
A new Global Cardiovascular Disease (CVD) Atlas portrays a divided world where rich countries are gradually freeing themselves from the yoke of CVD but where many poor and middle-income countries are still struggling. Ischemic heart disease and stroke were the two biggest contributors to the global burden of disease in 2010, accounting for 5.2% and […]